Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Todd Arnold, Daniel Sisco, Derrick Crook, Brian Hansen

Premium

Mt. Sinai is launching a new genetic testing laboratory in Branford, Conn., and has hired Todd Arnold to serve as the lab's managing director and Daniel Sisco to serve as director of laboratory operations.

Arnold was most recently vice president of research and development in Roche's 454 Life Sciences division, where he held several other positions. Before that, he was director of applications support, research and development at CUNO. He was also manager of DNA chemistry at Gamera Bioscience and a molecular biologist at Millipore.

Sisco was most recently director of Roche's 454 sequencing center. Before joining 454, he was a research specialist at EnGenCore.


Public Health England has named Derrick Crook as director of microbiology. In the role, Crook will lead the translation of genomic technologies to microbiology practice through partnerships with universities, PHE said.

Crook is a professor of microbiology in the Nuffield Department of Medicine at Oxford University, co-director of the Oxford Biomedical Research, Infection Theme, and a practicing clinical microbiologist and infectious disease physician at the Oxford University Hospitals NHS Trust.


Adaptive Biotechnologies has hired Brian Hansen as chief commercial officer. Previously, Hansen served as head of commercial, sales and marketing at Genoptix, which is owned by Novartis. Prior to that, he was senior vice president of global sales and service at Gen-Probe and vice president of sales at Thermo Fisher Scientific.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.